| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Smith Mark Douglas is a Director at Phreesia, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 12 sells.
Estimated insider holdings value: $2.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2025 | PHR Phreesia, Inc. | Director | Sale+OE | 7,000 | $29.00 | $203,000.00 | -15.8% | -19.1% | - | |
| Aug 15, 2024 | TDOC Teladoc Health, Inc. | Director | Buy | 4,000 | $7.08 | $28,312.00 | +91.8% | +35.6% | +6.5% | |
| Jul 18, 2024 | PHR Phreesia, Inc. | Director | Sale+OE | 7,000 | $25.00 | $175,000.00 | -18.6% | -7.9% | +12.5% | |
| Dec 4, 2023 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 417 | $119.27 | $49,735.59 | -5.7% | -3.2% | +0.2% | |
| Aug 14, 2023 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 1,241 | $138.16 | $171,453.95 | -14.5% | -12.9% | -20.2% | |
| Apr 3, 2023 | PHR Phreesia, Inc. | Director | Sale+OE | 7,000 | $30.77 | $215,367.25 | -17.6% | -1.1% | -25.3% | |
| Dec 2, 2022 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 420 | $154.68 | $64,965.85 | -7.1% | -8.2% | -24.3% | |
| Aug 8, 2022 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 1,089 | $152.32 | $165,879.20 | -15.6% | -5.7% | -14.2% | |
| Dec 2, 2021 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 417 | $121.30 | $50,582.10 | -8.6% | +24.8% | +28.2% | |
| Jan 4, 2021 | PHR Phreesia, Inc. | Director | Sale+OE | 6,000 | $52.57 | $315,410.85 | -21.6% | - | - |